Company
CND Life Sciences
| Industry | provider of an objective biomarker-based neurodiagnostics platform |
|---|
Funding raised
| Company | Round | Date |
|---|---|---|
| CND Life Sciences | Growth Funding | 2026-08-04 |
| CND Life Sciences | Series A3 | 2025-05-15 |
| CND Life Sciences | Series Seed 3 Funding | 2023-04-06 |